Mostrando 1,001 - 1,020 Resultados de 1,135 Para Buscar 'Ashenden: OR the British Agent*', tiempo de consulta: 0.28s Limitar resultados
  1. 1001
    “…Animals treated i.v. with single chain antibody fragments-liposomes containing the new cytotoxic agent 2′-deoxy-5-fluorouridylyl-N(4)-octadecyl-1-β-D-arabinofuranosylcytosine (30 mg kg(-1) per dose, five times every 24 h) showed a reduction of tumour growth by 62–90% determined on days 5 and 8, respectively, compared to animals receiving control liposomes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  2. 1002
  3. 1003
    “…One strategy to improve the outcome for patients is to add other agents to standard therapy. Doxil is active in relapsed disease and has a response rate of 25% in platinum-resistant relapsed disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  4. 1004
    por Moon, S E, Bhagavathula, N, Varani, J
    Publicado 2002
    “…These data indicate that keratinocyte-fibroblast interactions are mediated by multiple stimulating agents acting on specific receptors to induce signalling through different mitogen-activated protein kinase pathways leading to altered expression of key biological functions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  5. 1005
    “…This might be of importance in the development of anti-angiogenic agents based on interference with haemostasis. British Journal of Cancer (2002) 87, 1437–1444. doi:10.1038/sj.bjc.6600655 www.bjcancer.com © 2002 Cancer Research UK…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 1006
    “…BACKGROUND: Elderly patients have a long list of differentials for causes of acute confusion and altered consciousness levels, including infectious agents. In addition, elderly, retired patients often have more time to travel for tourism, particularly to exotic, warmer locations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 1007
  8. 1008
    por Conn, P Jeffrey
    Publicado 2018
    “…Jeff Conn (Vanderbilt Univ., USA) will summarize recent genetic studies that point to loss of function mutations in two novel G protein-coupled receptors in SCZ patients, and the discovery of novel positive allosteric modulators for these receptors that are providing a strong proof of concept for advancing selective agents to clinical evaluation in patients, including those that bear these specific mutations. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 1009
    “…The included studies will have assessed glycemic control of M. charantia preparations with placebo or standard oral anti-hyperglycemic agents in adult pre-diabetes and/or type 2 diabetes mellitus patients and have at least 4 weeks of follow-up. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 1010
  11. 1011
  12. 1012
  13. 1013
  14. 1014
  15. 1015
  16. 1016
    por Eindor, A, Meleady, L, Jacobson, K
    Publicado 2022
    “…Clinical remission was reported in 61.8% of patients on their first biologic agent at the last follow up. CONCLUSIONS: Factors influencing earlier progression to biologics were disease severity and disease behaviour. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 1017
  18. 1018
  19. 1019
  20. 1020
Herramientas de búsqueda: RSS